Tumor Embolization Market
Tumor Embolization Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Tumor Embolization Market Size and Growth
The Tumor Embolization market is experiencing significant growth, attributed to rising cancer incidence and advancements in minimally invasive techniques. The market size is estimated to reach approximately $1.5 billion by 2027, driven by increasing demand for targeted therapies and technological innovations, shaping a competitive landscape with numerous key players.
Companies Covered (Covid 19 Impact Covered)
◍ Boston Scientific Corporation
◍ Varian Medical Systems, Inc.
◍ Nordion (Sotera Health)
◍ Sirtex Medical
The tumor embolization market features key players like Boston Scientific, Varian Medical, Nordion, and Sirtex Medical, focusing on innovative embolization devices and therapies. These companies enhance market growth through product development, strategic partnerships, and clinical advancements. Sales revenue figures include:
- Boston Scientific: Approximately $11 billion
- Varian Medical Systems: Around $3 billion
- Sirtex Medical: About $250 million.
Market Segmentation
By Application
◍ Hospitals
◍ Ambulatory Surgical Centers
◍ Specialty Clinics
◍ Others
By Product
◍ Trans-Arterial Embolization (TAE)
◍ Drug-Eluting Bead Chemoembolization (DEB-TACE)
◍ Radioembolization (RE)
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ 2.61 Billion
